- Home
- KTTA vs ECPG Comparison
KTTA vs ECPG Comparison
Compare KTTA & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- ECPG
- Stock Information
- Founded
- KTTA 2020
- ECPG 1998
- Country
- KTTA United States
- ECPG United States
- Employees
- KTTA N/A
- ECPG N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- ECPG Finance Companies
- Sector
- KTTA Health Care
- ECPG Finance
- Exchange
- KTTA Nasdaq
- ECPG Nasdaq
- Market Cap
- KTTA 5.5M
- ECPG 806.1M
- IPO Year
- KTTA 2021
- ECPG 1999
- Fundamental
- Price
- KTTA $0.73
- ECPG $41.17
- Analyst Decision
- KTTA
- ECPG Strong Buy
- Analyst Count
- KTTA 0
- ECPG 3
- Target Price
- KTTA N/A
- ECPG $62.67
- AVG Volume (30 Days)
- KTTA 166.4K
- ECPG 262.2K
- Earning Date
- KTTA 08-12-2025
- ECPG 08-06-2025
- Dividend Yield
- KTTA N/A
- ECPG N/A
- EPS Growth
- KTTA N/A
- ECPG N/A
- EPS
- KTTA N/A
- ECPG N/A
- Revenue
- KTTA N/A
- ECPG $1,380,750,000.00
- Revenue This Year
- KTTA N/A
- ECPG $21.70
- Revenue Next Year
- KTTA N/A
- ECPG $8.86
- P/E Ratio
- KTTA N/A
- ECPG N/A
- Revenue Growth
- KTTA N/A
- ECPG 11.49
- 52 Week Low
- KTTA $0.70
- ECPG $26.45
- 52 Week High
- KTTA $7.50
- ECPG $51.77
- Technical
- Relative Strength Index (RSI)
- KTTA 36.47
- ECPG 63.36
- Support Level
- KTTA $0.70
- ECPG $38.37
- Resistance Level
- KTTA $0.76
- ECPG $39.86
- Average True Range (ATR)
- KTTA 0.04
- ECPG 1.04
- MACD
- KTTA 0.01
- ECPG 0.17
- Stochastic Oscillator
- KTTA 21.88
- ECPG 94.97
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.